BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22916712)

  • 1. Expression of cassini, a murine gamma-satellite sequence conserved in evolution, is regulated in normal and malignant hematopoietic cells.
    Arutyunyan A; Stoddart S; Yi SJ; Fei F; Lim M; Groffen P; Feldhahn N; Groffen J; Heisterkamp N
    BMC Genomics; 2012 Aug; 13():418. PubMed ID: 22916712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia.
    Ma H; Mallampati S; Lu Y; Sun B; Wang E; Leng X; Gong Y; Shen H; Yin CC; Jones D; Amin HM; You MJ; Zweidler-McKay P; Ma Y; Kantarjian HM; Arlinghaus RB; Glassman A; Sun X
    Haematologica; 2014 Oct; 99(10):1591-8. PubMed ID: 24997151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway.
    Belton A; Xian L; Huso T; Koo M; Luo LZ; Turkson J; Page BD; Gunning PT; Liu G; Huso DL; Resar LM
    Leuk Lymphoma; 2016 Nov; 57(11):2681-4. PubMed ID: 26952843
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.
    Vilas-Zornoza A; Agirre X; Abizanda G; Moreno C; Segura V; De Martino Rodriguez A; José-Eneriz ES; Miranda E; Martín-Subero JI; Garate L; Blanco-Prieto MJ; García de Jalón JA; Rio P; Rifón J; Cigudosa JC; Martinez-Climent JA; Román-Gómez J; Calasanz MJ; Ribera JM; Prósper F
    Leukemia; 2012 Jul; 26(7):1517-26. PubMed ID: 22307227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both Down syndrome and non-Down syndrome genetic backgrounds.
    Gant VU; Junco JJ; Terrell M; Rashid R; Rabin KR
    PLoS One; 2021; 16(1):e0244863. PubMed ID: 33411777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies.
    Andersson A; Edén P; Olofsson T; Fioretos T
    BMC Med Genomics; 2010 Mar; 3():6. PubMed ID: 20211010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
    Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
    J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity.
    Satwani P; Bavishi S; Saha A; Zhao F; Ayello J; van de Ven C; Chu Y; Cairo MS
    Cytotherapy; 2014 Oct; 16(10):1431-40. PubMed ID: 24856896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells.
    Hsieh YT; Gang EJ; Shishido SN; Kim HN; Pham J; Khazal S; Osborne A; Esguerra ZA; Kwok E; Jang J; Bonig H; Biediger RJ; Vanderslice P; Kim YM
    Leukemia; 2014 Oct; 28(10):2101-4. PubMed ID: 24903479
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.
    Francis OL; Milford TA; Martinez SR; Baez I; Coats JS; Mayagoitia K; Concepcion KR; Ginelli E; Beldiman C; Benitez A; Weldon AJ; Arogyaswamy K; Shiraz P; Fisher R; Morris CL; Zhang XB; Filippov V; Van Handel B; Ge Z; Song C; Dovat S; Su RJ; Payne KJ
    Haematologica; 2016 Apr; 101(4):417-26. PubMed ID: 26611474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
    Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
    Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
    Duque-Afonso J; Smith KS; Cleary ML
    PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS).
    Krause S; Pfeiffer C; Strube S; Alsadeq A; Fedders H; Vokuhl C; Loges S; Waizenegger J; Ben-Batalla I; Cario G; Möricke A; Stanulla M; Schrappe M; Schewe DM
    Blood; 2015 Jan; 125(5):820-30. PubMed ID: 25428221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias.
    Ma C; Staudt LM
    Blood; 1996 Jan; 87(2):734-45. PubMed ID: 8555498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.
    Kasai S; Furuichi Y; Ando N; Kagami K; Abe M; Nakane T; Goi K; Inukai T; Saitoh S; Ohno S; Okazaki S; Nagano O; Saya H; Sugita K
    Cell Death Dis; 2017 Jun; 8(6):e2857. PubMed ID: 28569787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.
    Ford AM; Palmi C; Bueno C; Hong D; Cardus P; Knight D; Cazzaniga G; Enver T; Greaves M
    J Clin Invest; 2009 Apr; 119(4):826-36. PubMed ID: 19287094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the importance of multidrug resistance-associated protein 1 and P-glycoprotein to drug sensitivity in immortalized mouse embryonic fibroblasts.
    Lin ZP; Johnson DR; Finch RA; Belinsky MG; Kruh GD; Sartorelli AC
    Mol Cancer Ther; 2002 Oct; 1(12):1105-14. PubMed ID: 12481434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence and expression of Friend erythroleukemia virus-related sequences in normal and leukemic mouse tissues.
    Bernstein A; Gamble C; Penrose D; Mak TW
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4455-9. PubMed ID: 291976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.